Income Statement
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
CELZ
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0.01 | 0.01 | 0.01 | 0.09 | 0.09 | 0.16 | 0.17 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 |
|
Cost of Revenue
|
0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.05 | 0.05 | 0.07 | 0.01 | - | - | - | - | - | - |
|
Gross Profit
|
0.00 | 0.01 | 0.01 | 0.06 | 0.04 | 0.11 | 0.12 | 0.05 | 0.00 | - | - | - | - | - | - |
|
Operating Expenses
|
6.15 | 5.75 | 5.63 | 10.30 | 3.17 | 1.23 | 1.25 | 1.17 | 1.17 | 0.76 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
|
Research & Development
|
2.26 | 2.40 | 1.97 | 6.27 | 0.11 | - | 0.00 | 0.10 | 0.26 | 0.09 | - | - | - | - | - |
|
Selling, General & Administrative
|
3.76 | 3.24 | 3.56 | 3.94 | 2.96 | 1.16 | 1.22 | 1.05 | 0.90 | 0.66 | - | - | - | - | - |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-6.14 | -5.74 | -5.62 | -10.24 | -3.13 | -1.11 | -1.13 | -1.11 | -1.18 | -0.76 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
|
Non-Operating Income
|
0.15 | 0.25 | 0.33 | 0.10 | 22.34 | -35.21 | -7.35 | -12.54 | -1.48 | - | - | - | - | - | 0.00 |
|
Interest Income
|
- | - | 0.03 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | 0.00 | 4.28 | 1.23 | 1.90 | 1.36 | 0.38 | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-6.00 | -5.49 | -5.29 | -10.14 | 19.21 | -36.33 | -8.48 | -13.66 | - | - | - | - | - | - | -0.02 |
|
Income Tax Expense
|
0.00 | -5.49 | 0.00 | -10.14 | 0.00 | -36.33 | 0.00 | -13.66 | - | - | - | - | - | - | 0.00 |
|
Non-Controlling Interest
|
0.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-6.00 | 0.00 | -5.29 | 0.00 | 19.21 | 0.00 | -8.48 | 0.00 | -2.66 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | -0.02 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-6.14 | -5.74 | -5.62 | -10.24 | -3.13 | -1.11 | -1.13 | -1.11 | -1.18 | -0.76 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
|
Earnings Per Share (Basic)
|
- | - | - | -0.93 | 7.37 | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-2.52 | -3.71 | - | -0.93 | 5.61 | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
- | - | - | 10.93 | 2.61 | - | - | - | - | - | 18.11 | 18.11 | 18.11 | - | - |
|
Diluted Weighted Avg Shares
|
2.38 | 1.48 | - | 10.93 | 3.25 | - | - | - | - | - | - | - | - | 18.11 | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |